RYAN Ryan Specialty (RYAN) Insider Trading, Ownership & Congress Trades
Insurance · Insurance agents, brokers & service · CIK 0001849253
Cluster · 5 insidersC-suite buying · 3Form 144 · 2
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
198
13F, latest reported quarter
Conversions, 180 days
3
Codes C/M, not in net · $0 priced
What the filings say about RYAN
Insiders, 180 days
+$2.9M net bought
5 buyers · 2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.7M
2 notices
Ryan Specialty insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, RYAN SPECIALTY HOLDINGS, INC. insiders bought a net $2.9M of stock across 198 Form 4 purchases and sales, with 5 insiders buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Mar 14, 2025.
- The trade is 53.1% of the 75,366 shares held after it.
- 1 other insider sold within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-President and CRO MULSHINE BRENDAN MARTIN sold about $1.6M of RYAN on Sep 8, 2026; 1 other insider sold within 30 days and 198 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 25.1% of the 8,153 shares held after it.
- 1 other insider sold within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & CHRO Conklin Michael sold about $86.3K of RYAN on Aug 13, 2026; 1 other insider sold within 30 days and 198 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Jun 11, 2026.
- +0.2% median (+0.2% mean) 90-day return after 2 previous buys.
- The trade is 3.8% of the 13,072 shares held after it.
- 4 other insiders bought within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Kuczinski Anthony J bought about $17.9K of RYAN on Jun 12, 2026; 4 other insiders bought within 30 days and 198 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 12, 2025.
- The trade is 19.9% of the 12,572 shares held after it.
- 4 other insiders bought within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Kuczinski Anthony J bought about $87.1K of RYAN on Jun 11, 2026; 4 other insiders bought within 30 days and 198 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Jul 26, 2021.
- The trade is 6.4% of the 117,933 shares held after it.
- 4 other insiders bought within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ROGERS JOHN W JR bought about $263.7K of RYAN on Jun 10, 2026; 4 other insiders bought within 30 days and 198 funds added in the latest 13F quarter.198 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$2.9M over 180 days
-$1.7M over 90 days · +$3.9M of it by a 10%+ holder
more than 96% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
198 funds bought in last quarter
more than 62% of Insurance
Revenue
+21.9% year over year
more than 71% of Insurance
Margin
2.1% net margin
below 78% of Insurance
Buybacks
$300.2M repurchased, FY to 2026-06-30
more than 66% of Insurance
Short interest
12.3% of the float short (float per yahoo 2026-10-26) · 5.6 days to cover · settled 2026-09-30
more than 97% of Insurance
The situation: each line is one rule over one dataset
5 insiders bought a net $2.9M, but 2 Form 144 notices ($1.7M) are queued to sell.
What changed in the last 30 days
Oct 27Insider buying stopped: no purchases in 90 days after 6 in the prior 90
Why it matters
The absence is the signal: 6 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch RYAN
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-16.5%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns RYAN: institutional holders (13F)
13F holdings, latest reported quarter
10,494,326 sh
$396.3M
7,912,669 sh
$298.8M
6,307,845 sh
$238.2M
5,572,840 sh
$210.5M
5,266,873 sh
$198.9M
Congress trades in RYAN
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
RYAN planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
BRENDAN MARTIN MULSHINE
Filed 2026-09-08
$1.6M
MICHAEL LAVERN CONKLIN
Filed 2026-08-13
$86.3K
RYAN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Vulcan Value Partners Fund
$16.1M position · as of 2026-07-31
7.0%
Vulcan Value Partners Small Cap Fund
$5.6M position · as of 2026-07-31
6.9%
Virtus KAR Small-Cap Growth Fund
$28.3M position · as of 2026-06-30
4.6%
Virtus KAR Small-Cap Growth Series
$2.2M position · as of 2026-06-30
4.6%
Clarkston Founders Fund
$2.6M position · as of 2026-06-30
3.6%
Virtus KAR Global Small-Cap Fund
$1.2M position · as of 2026-06-30
3.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Patrick G.Ryan
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$4.3M
$4.3M
$2.6M
+56%
+9%
2022
$4.5M
$4.5M
$2.5M
+51%
-3%
2021
$2.5M
$2.5M
$9.0M
+47%
+9%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
5 insiders reported buying shares.
The record shows a net $2.9M bought by insiders over 180 days, 198 funds added last quarter, $1.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
RYAN financials
Revenue growth
+21.9%
XBRL, annual
Net margin
2.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM RYAN
| FY Dec 2025 | $3.1B |
| FY Dec 2024 | $2.5B |
| FY Dec 2023 | $2.1B |
| FY Dec 2022 | $1.7B |
| FY Dec 2021 | $1.4B |
| Jun 2026 | $916.6M |
| Mar 2026 | $795.2M |
| Dec 2025 | $751.2M |
| Sep 2025 | $754.6M |
| Jun 2025 | $855.2M |
| Mar 2025 | $690.2M |
| Dec 2024 | $663.5M |
| Sep 2024 | $604.7M |
At each fiscal year end
Single quarter
Net margin, TTM
+3.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM RYAN
| FY Dec 2025 | +2.1% |
| FY Dec 2024 | +3.8% |
| FY Dec 2023 | +2.9% |
| FY Dec 2022 | +3.5% |
| FY Dec 2021 | +4.6% |
| Jun 2026 | +4.6% |
| Mar 2026 | +2.2% |
| Dec 2025 | +1.1% |
| Sep 2025 | +4.1% |
| Jun 2025 | +6.1% |
| Mar 2025 | -4.0% |
| Dec 2024 | +2.1% |
| Sep 2024 | +2.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$554.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM RYAN
| FY Dec 2025 | $640.7M |
| FY Dec 2024 | $514.9M |
| FY Dec 2023 | $477.2M |
| FY Dec 2022 | $327.8M |
| FY Dec 2021 | -$69.7M |
| Jun 2026 | $291.5M |
| Mar 2026 | -$167.4M |
| Dec 2025 | $263.2M |
| Sep 2025 | $167.3M |
| Jun 2025 | $353.6M |
| Mar 2025 | -$143.5M |
| Dec 2024 | $259.6M |
| Sep 2024 | $100.9M |
At each fiscal year end
Single quarter
Debt to equity
7.13x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity RYAN
| FY Dec 2025 | 5.17x |
| FY Dec 2024 | 5.23x |
| FY Dec 2023 | 3.54x |
| FY Dec 2022 | 4.14x |
| FY Dec 2021 | 2.67x |
| Jun 2026 | 7.13x |
| Mar 2026 | 5.61x |
| Dec 2025 | 5.17x |
| Sep 2025 | 5.38x |
| Jun 2025 | 5.69x |
| Mar 2025 | 6.80x |
| Dec 2024 | 5.23x |
| Sep 2024 | 4.23x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.15x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt RYAN
| FY Dec 2025 | 0.19x |
| FY Dec 2024 | 0.16x |
| FY Dec 2023 | 0.24x |
| FY Dec 2022 | 0.17x |
| FY Dec 2021 | 0.17x |
| Jun 2026 | 0.15x |
| Mar 2026 | 0.17x |
| Dec 2025 | 0.19x |
| Sep 2025 | 0.19x |
| Jun 2025 | 0.16x |
| Mar 2025 | 0.13x |
| Dec 2024 | 0.16x |
| Sep 2024 | 0.18x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+17.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity RYAN
| FY Dec 2025 | +9.9% |
| FY Dec 2024 | +15.9% |
| FY Dec 2023 | +11.8% |
| FY Dec 2022 | +11.4% |
| FY Dec 2021 | +11.1% |
| Jun 2026 | +17.7% |
| Mar 2026 | +18.4% |
| Dec 2025 | +9.9% |
| Sep 2025 | +11.0% |
| Jun 2025 | +9.2% |
| Mar 2025 | +9.2% |
| Dec 2024 | +15.9% |
| Sep 2024 | +17.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets RYAN
| FY Dec 2025 | +0.6% |
| FY Dec 2024 | +1.1% |
| FY Dec 2023 | +0.9% |
| FY Dec 2022 | +1.0% |
| FY Dec 2021 | +1.3% |
| Jun 2026 | +0.9% |
| Mar 2026 | +1.0% |
| Dec 2025 | +0.6% |
| Sep 2025 | +0.8% |
| Jun 2025 | +0.6% |
| Mar 2025 | +0.6% |
| Dec 2024 | +1.1% |
| Sep 2024 | +1.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+10.2%
operating income after a 14.0% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital RYAN
| FY Dec 2025 | +9.9% |
| FY Dec 2024 | +11.3% |
| FY Dec 2023 | +18.5% |
| FY Dec 2022 | +18.2% |
| FY Dec 2021 | +14.7% |
| Jun 2026 | +10.2% |
| Mar 2026 | +11.0% |
| Dec 2025 | +9.9% |
| Sep 2025 | +9.5% |
| Jun 2025 | +9.0% |
| Mar 2025 | +8.0% |
| Dec 2024 | +11.3% |
| Sep 2024 | +14.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+8.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed RYAN
| FY Dec 2025 | +9.4% |
| FY Dec 2024 | +9.9% |
| FY Dec 2023 | +10.6% |
| FY Dec 2022 | +10.0% |
| FY Dec 2021 | +8.1% |
| Jun 2026 | +8.9% |
| Mar 2026 | +8.8% |
| Dec 2025 | +9.4% |
| Sep 2025 | +10.3% |
| Jun 2025 | +10.8% |
| Mar 2025 | +10.2% |
| Dec 2024 | +9.9% |
| Sep 2024 | +10.4% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing RYAN
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$8.3B
market value at close 2026-10-23 on 2021-09-01 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value RYAN
| FY Dec 2025 | $8.9B |
| FY Dec 2024 | $9.8B |
| FY Dec 2023 | $5.9B |
| FY Dec 2022 | $5.6B |
| FY Dec 2021 | $4.9B |
| Jun 2026 | $7.6B |
| Mar 2026 | $7.1B |
| Dec 2025 | $8.9B |
| Sep 2025 | $9.4B |
| Jun 2025 | $10.8B |
| Mar 2025 | $11.6B |
| Dec 2024 | $9.8B |
| Sep 2024 | $9.7B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+11.6%
TTM free cash flow over market value at close 2026-10-23
FCF yield RYAN
| FY Dec 2025 | +11.3% |
| FY Dec 2024 | +7.3% |
| FY Dec 2023 | +10.1% |
| FY Dec 2022 | +7.2% |
| FY Dec 2021 | -1.6% |
| Jun 2026 | +13.4% |
| Mar 2026 | +16.6% |
| Dec 2025 | +11.3% |
| Sep 2025 | +10.3% |
| Jun 2025 | +7.6% |
| Mar 2025 | +6.0% |
| Dec 2024 | +7.3% |
| Sep 2024 | +6.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing RYAN
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $3.1B | $2.5B | $2.1B | $1.7B |
| Operating income | $493.6M | $427.8M | $359.1M | $289.5M |
| Net income | $63.4M | $94.7M | $61.0M | $61.1M |
| Operating cash flow | $643.7M | $514.9M | $477.2M | $335.5M |
| Cash | $158.3M | $540.2M | $838.8M | $992.7M |
| Long-term debt | $3.3B | $3.2B | $1.9B | $2.0B |
| Dividends paid | $62.3M | $80.2M | $0 | $0 |
SEC XBRL, fiscal years, as known on 2026-10-27
RYAN Stock Sonar score 6/7 axes
Find similar shapesCompareRYAN ranks highest on insider conviction (96th percentile) and growth (71st), and lowest on financial health (10th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
RYAN filings, in plain words
Are Ryan Specialty insiders buying or selling RYAN?
In the 180 days to 2026-10-27, Ryan Specialty insiders were net buyers, a net $2.9M: $4.6M of purchases and $1.7M of sales reported on Form 4, by 5 buyers and 2 sellers.
Are there planned insider sales of RYAN?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.7M of stock; the latest, by BRENDAN MARTIN MULSHINE, was filed 2026-09-08.
Read the full summary
In the 180 days to 2026-10-27, Ryan Specialty insiders were net buyers of RYAN, a net $2.9M across purchases and sales reported on Form 4 by 5 buyers and 2 sellers. Most of that figure, $3.9M, came from a holder of 10% or more rather than an officer or director. 5 insiders reported purchases in that window. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
